OTHER INFORMATION.
−Removed: Rule 10b5-1 Trading Arrangements and Non-Rule 10b5-1
−Removed: Trading Arrangements
−Removed: During the fiscal quarter ended March 31, 2025, none of our officers or directors, as those terms are defined in
−Removed: Rule 16a-1(f), adopted or terminated a “Rule 10b5-1 trading arrangement” or a “non-Rule 10b5-1 trading arrangement,”
−Removed: as those terms are defined in Item 408 of Regulation S-K.
−Removed: See the Exhibit Index following the signature page
−Removed: to this Quarterly Report on Form 10-Q for a list of exhibits filed or furnished with this report, which Exhibit Index is incorporated
−Removed: herein by reference.
−Removed: Pursuant to the requirements
−Removed: of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto
−Removed: duly authorized.
+Added: 10b5-1 Trading Arrangements and Non-Rule 10b5-1 Trading Arrangements
+Added: the fiscal quarter ended June 30, 2025, none of our officers or directors, as those terms are defined in Rule 16a-1(f), adopted or terminated
+Added: a “Rule 10b5-1 trading arrangement” or a “non-Rule 10b5-1 trading arrangement,” as those terms are defined in
+Added: Item 408 of Regulation S-K.
+Added: the Exhibit Index following the signature page to this Quarterly Report on Form 10-Q for a list of exhibits filed or furnished with this
+Added: report, which Exhibit Index is incorporated herein by reference.
+Added: to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
+Added: the undersigned thereunto duly authorized.
MATINAS BIOPHARMA HOLDINGS, INC.
−Removed: /s/ Jerome D.
+Added: August 14, 2025
Chief Executive Officer (Principal Executive Officer)
+Added: August 14, 2025
Chief Financial Officer
(Principal Financial and Accounting Officer)
−Removed: EXHIBIT INDEX
Certificate of Incorporation (incorporated by reference to Exhibit 3.1 to Amendment No.
6 unchanged sentences
Form of Certificate of Designation of Series C Convertible Preferred Stock (filed as an exhibit to the Current Report on Form 8-K filed with the Commission on February 13, 2025 and incorporated herein by reference).
−Removed: Common Stock Purchase Warrant, dated April 5, 2024 (incorporated herein by reference to the Company’s Current Report on Form 8-K filed with the SEC on April 5, 2024).
+Added: Certificate of Amendment of Certificate of Incorporation, as amended, of Matinas BioPharma Holdings, Inc., dated August 6, 2025 (filed as an exhibit to the Current Report on Form 8-K filed with the Commission on August 6, 2025 and incorporated herein by reference)
+Added: Form of Common Stock Purchase Warrant, dated April 5, 2024 (incorporated herein by reference to the Company’s Current Report on Form 8-K filed with the SEC on April 5, 2024).
Description of Securities (filed as an exhibit to the Annual Report on Form 10-K filed with the Commission on April 15, 2025 and incorporated herein by reference).
−Removed: Form of Common Stock Purchase Warrant (filed as an exhibit to the Current Report on Form 8-K filed with the Commission on April 5, 2024 and incorporated herein by reference)
−Removed: Form of Warrant (filed as an exhibit to the Current Report on Form 8-K filed with the Commission on February 13, 2025 and incorporated herein by reference)
+Added: Form of Common Stock Purchase Warrant (filed as an exhibit to the Current Report on Form 8-K filed with the Commission on February 13, 2025 and incorporated herein by reference)
+Added: Form of Amendment to Common Stock Purchase Warrant*
Form of Securities Purchase Agreement (filed as an exhibit to the Current Report on Form 8-K, filed with the Commission on February 13, 2025 and incorporated herein)
3 unchanged sentences
Inline XBRL Instance Document.
−Removed: Inline XBRL Taxonomy Extension Schema Document.
−Removed: Inline XBRL Taxonomy Extension Calculation Linkbase Document.
−Removed: Inline XBRL Taxonomy Extension Definition Linkbase Document.
−Removed: Inline XBRL Taxonomy Extension Label Linkbase Document.
−Removed: Inline XBRL Taxonomy Extension Presentation Linkbase Document.
−Removed: Cover Page Interactive Data File (embedded within the Inline XBRL document)
+Added: Inline XBRL Taxonomy Extension
+Added: Schema Document.
+Added: Inline XBRL Taxonomy Extension
+Added: Calculation Linkbase Document.
+Added: Inline XBRL Taxonomy Extension
+Added: Definition Linkbase Document.
+Added: Inline XBRL Taxonomy Extension
+Added: Label Linkbase Document.
+Added: Inline XBRL Taxonomy Extension
+Added: Presentation Linkbase Document.
+Added: Cover Page Interactive
+Added: Data File (embedded within the Inline XBRL document)
Filed herewith.
−Removed: † Indicates a management contract or compensation
−Removed: plan, contract or arrangement.
−Removed: Certain portions of this exhibit, that are not material and would likely cause competitive harm to the
−Removed: registrant if publicly disclosed, have been redacted pursuant to Item 601(b)(10) of Regulation S-K.
+Added: Indicates a management contract or compensation plan, contract or arrangement.
+Added: Certain portions of this exhibit, that are not material
+Added: and would likely cause competitive harm to the registrant if publicly disclosed, have been redacted pursuant to Item 601(b)(10) of Regulation
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.